Growth Metrics

Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023)

Mesoblast recorded quarterly Asset Utilization Ratio of 0.01 in Q1 2023, up 1.62% quarter-over-quarter from 0.01 in Q4 2022, and down 9.49% year-over-year from 0.01 in Q1 2022.

Mesoblast's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q1 2023.

  • In Q1 2023, Asset Utilization Ratio fell 9.49% year-over-year to 0.01; the TTM figure through Mar 2023 stood at 0.01 (down 9.49% YoY), while the FY2025 annual figure was 0.02, changed N/A from the prior year.
  • Asset Utilization Ratio came in at 0.01 for Q1 2023 at Mesoblast, up from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q2 2020 to a low of 0.01 in Q1 2019.
  • A 5-year average of 0.02 and a median of 0.01 in 2021 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio soared 483.17% in 2020 and tumbled 78.4% in 2021, its largest moves.
  • Mesoblast's Asset Utilization Ratio stood at 0.01 in 2019, then surged by 346.56% to 0.05 in 2020, then slumped by 73.02% to 0.01 in 2021, then dropped by 7.8% to 0.01 in 2022, then rose by 1.62% to 0.01 in 2023.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.47
7 Evaxion A 64.16 Bn 64.14 Bn - 0.29
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.85
10 Mesoblast 23.40 Bn 23.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.04
Dec 31, 2020 0.05
Sep 30, 2020 0.04
Jun 30, 2020 0.05
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.01
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.01
Sep 30, 2018 0.01
Jun 30, 2018 0.01
Mar 31, 2018 0.01
Dec 31, 2017 0.01
Sep 30, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.04